{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:30:12Z","timestamp":1791329412801,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1124\/jpet.110.167916","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T01:34:32Z","timestamp":1274232872000},"page":"609-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["In Vitro\u2013In Vivo Extrapolation Predicts Drug\u2013Drug Interactions Arising from Inhibition of Codeine Glucuronidation by Dextropropoxyphene, Fluconazole, Ketoconazole, and Methadone in Humans"],"prefix":"10.1016","volume":"334","author":[{"given":"Pritsana","family":"Raungrut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verawan","family":"Uchaipichat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamas","family":"Janchawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Miners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.167916_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00544251","article-title":"The pharmacokinetics of ketoconazole after chronic administration in adults","volume":"33","author":"Badcock","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00008571-200011000-00002","article-title":"Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance","volume":"10","author":"Bhasker","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/jpet.110.167916_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2125.2002.01669.x","article-title":"In vitro\u2013in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine","volume":"54","author":"Boase","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/dmd.109.030676","article-title":"Investigation into UDP-glucuronosyltransferase enzyme kinetics of imidazole and triazole containing antifungal drugs in human liver microsomes and recombinant UGT enzymes","volume":"38","author":"Bourcier","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.2005.02446.x","article-title":"S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen","volume":"60","author":"Bowalgaha","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2125.2005.02483.x","article-title":"Prediction of in vivo drug\u2013drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant","volume":"60","author":"Brown","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.1991.tb05550.x","article-title":"Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers","volume":"31","author":"Chen","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/dmd.31.9.1125","article-title":"Evaluation of 3\u2032-azido-3\u2032-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism","volume":"31","author":"Court","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-198814010-00002","article-title":"Clinical pharmacokinetics of ketoconazole","volume":"14","author":"Daneshmend","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.110.167916_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2125.2004.02079.x","article-title":"Population pharmacokinetics of (R)-, (S)-, and rac-methadone in methadone maintenance patients","volume":"57","author":"Foster","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib11","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1056\/NEJMoa041888","article-title":"Codeine intoxication associated with ultrarapid CYP2D6 metabolism","volume":"351","author":"Gasche","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.110.167916_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/j.1552-4604.1978.tb02429.x","article-title":"Plasma protein binding of d-propoxyphene in normal and anephric patients","volume":"18","author":"Giacomini","year":"1978","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/cpt1979264473","article-title":"d-Propoxyphene kinetics after single and oral intravenous doses in man","volume":"26","author":"Gram","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.167916_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.1987.47","article-title":"Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain","volume":"41","author":"Inturrisi","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.167916_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/clpt.1982.25","article-title":"Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene","volume":"31","author":"Inturrisi","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.167916_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2125.2003.02041.x","article-title":"Database analyses for the prediction of in vivo drug\u2013drug interactions from in vitro data","volume":"57","author":"Ito","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/abbi.1997.9949","article-title":"The regio- and stereo-selectivity of C19 and C21 hydroxysteroid glucuronidation by UGT2B7 and UGT2B11","volume":"341","author":"Jin","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/jpet.110.167916_bib18","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1124\/dmd.109.028225","article-title":"Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltrannsferase 1A1, 1A6, 1A9, 2B7, and 2B10","volume":"37","author":"Kerdpin","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/dmd.108.023853","article-title":"Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes","volume":"37","author":"Kilford","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.2008.157","article-title":"Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study","volume":"85","author":"Madadi","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.167916_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00042560-199808150-00004","article-title":"Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)","volume":"18","author":"McCance-Katz","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1124\/jpet.110.167916_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.2000.00193.x","article-title":"Nonspecific binding of drugs to human liver microsomes","volume":"49","author":"McLure","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib23","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.bcp.2005.12.019","article-title":"In vitro\u2013in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises","volume":"71","author":"Miners","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/03602530903210716","article-title":"The prediction of drug glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro\u2013in vivo extrapolation of drug clearance and drug\u2013drug interaction potential","volume":"42","author":"Miners","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/jpet.110.167916_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2125.2005.02573.x","article-title":"Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids","volume":"61","author":"Morrish","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/dmd.107.019885","article-title":"The albumin effect and in vitro\u2013in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9","volume":"36","author":"Rowland","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","article-title":"In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine\u2013valproic acid interaction","volume":"34","author":"Rowland","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.106.118216","article-title":"Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro\u2013in vivo extrapolation","volume":"321","author":"Rowland","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.167916_bib30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.108.021105","article-title":"The \u201calbumin effect\u201d and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities","volume":"36","author":"Rowland","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/169.5.1103","article-title":"Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus","volume":"169","author":"Sahai","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1124\/jpet.110.167916_bib32","unstructured":"Segel IH (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, pp 104 and 129, J. Wiley and Sons, New York."},{"key":"10.1124\/jpet.110.167916_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.301.1.382","article-title":"In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance","volume":"301","author":"Soars","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.167916_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1124\/jpet.110.167916_bib35","first-page":"45","article-title":"Methadone inhibits CYP2D6 and UGT2B7 in vivo: a study using codeine as the substrate","volume":"41","author":"Somogyi","year":"2009","journal-title":"Drug Metab Rev"},{"key":"10.1124\/jpet.110.167916_bib36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.106.009738","article-title":"Inhibition of UDP-glucuronosyltransferase 2B7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode","volume":"34","author":"Takeda","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/FPC.0b013e32832e0eac","article-title":"Codeine and morphine pathway","volume":"19","author":"Thorn","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.110.167916_bib38","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/AAC.42.7.1592","article-title":"Glucuronidation of 3\u2032-azido-3\u2032-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid","volume":"42","author":"Trapnell","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.110.167916_bib39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human UDP-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.167916_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2006.02588.x","article-title":"Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation","volume":"61","author":"Uchaipichat","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167916_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cpt1976195part1559","article-title":"Propoxyphene and norpropoxyphene: influence of diet and and fluid on plasma levels","volume":"19","author":"Welling","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.167916_bib43","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/1078-0432.CCR-05-0703","article-title":"Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes","volume":"11","author":"Yong","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.110.167916_bib44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2125.1991.tb05585.x","article-title":"Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine","volume":"31","author":"Yue","year":"1991","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.167916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:16:16Z","timestamp":1740017776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524459326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022356524459326"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.167916","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro\u2013In Vivo Extrapolation Predicts Drug\u2013Drug Interactions Arising from Inhibition of Codeine Glucuronidation by Dextropropoxyphene, Fluconazole, Ketoconazole, and Methadone in Humans","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.167916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}